<

National major new drug special will be aimed at the classic Chinese side of the development

  February 22, the Ministry of Science and Technology organized a major new drug to create a national science and technology major news conference, China's major focus on major projects to adjust the major varieties and key technology research and development, core technology innovation platform and capacity-building, including the focus on traditional Chinese medicine Side development, and has the advantages of traditional Chinese medicine compound and its active ingredients and other research.

  New Technology Specialist, the Chinese Academy of Engineering, Sang Guowei said that the "three five" period, the new drug will enhance the special drug non-clinical research quality management standard certification (GLP) platform innovation and international competitiveness, to its full Play a new chain of innovation and innovation services to guide the service, to protect the safety of drugs and innovative drugs into the international first echelon.

  The next step, the national major projects will focus on the task to adjust to major varieties and key technology research and development, core technology innovation platform and capacity building. Grasp the forefront of international technology development, research and development with new structures, new targets and new mechanisms of action of major innovative varieties. Promote multi-disciplinary collaborative innovation, focusing on the development of traditional Chinese medicine classic, and has the characteristics of traditional Chinese medicine compound and its active ingredients and other research. Accelerate the development of clinical needs of the urgent need to accelerate the stage in the clinical trials of key varieties (more than 200) of the R & D process, breaking a number of high-end agents and other core key technologies. Fully relying on the new drug has been built a variety of technical platforms, the State Key Laboratory, to promote the sharing of resources, the establishment of multi-disciplinary cross, the depth of integration of production and research collaborative innovation mechanism.

  New medicine special implementation 8 years, China's bio-pharmaceutical industry research and development innovation and industrial development continued to increase, as of the "second five" at the end, a total of 90 varieties of new drug certificates, 135 varieties of clinical approval. New drug research and innovation ability to be internationally recognized, to the Austrian heart health, Salvia capsules and other access to the EU license. Modern Chinese medicine new drug discovery and evaluation technology platform construction and other five projects won the national scientific and technological progress award. Biological macromolecules drug administration, secondary development of Chinese medicine and a number of bottlenecks key technology breakthrough. According to preliminary statistics, the new drug special central government investment of 12.8 billion, to achieve direct economic benefits of 160 billion.

  Major Commissioner of the Office of Chen Chuanhong presided over the meeting, the new drug special implementation of the Office of Management Director, National Health and Health Committee Director of Science and Education Qin Huaijin introduced the overall progress of major national science and technology projects.

【Disclaimer】

This article is reproduced, only for the exchange, does not mean that the views of this site, the site is not responsible for the authenticity of the content, hereby declare. If you are interested in the contents of the work, copyright and other issues, please contact us in the 30 days, we will be the first time to remove or replace the relevant content, but not related to the commitment to compensation. This article copyright and content interpretation of the original author of all.